$VYNE News

VYNE Therapeutics Q1 EPS $(0.08) Beats $(0.18) Estimate, Sales $86.000K Miss $200.000K Estimate

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement

VYNE Therapeutics Inc. (VYNE) Yarrow Bioscience, Inc. - M&A Call Prepared Remarks Transcript

VYNE Therapeutics shares are trading higher after the company announced it entered into a definitive merger agreement pursuant to combine with Yarrow Bioscience.

VYNE Therapeutics shares are trading higher after the company announced it entered into a definitive merger agreement pursuant to combine with Yarrow Bioscience.

Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times

VYNE Therapeutics Enters All-Stock Merger With Yarrow Bioscience, Combined Co. Will Operate As Yarrow Bioscience

Trading Halt: Halted at 7:55:00 a.m. ET - Trading Halt: Halt News Pending

VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update

VYNE Therapeutics Q3 EPS $(0.17) Misses $(0.13) Estimate, Sales $169.000K Beat $100.000K Estimate

VYNE Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update

VYNE Therapeutics Q2 EPS $(0.13) Beats $(0.22) Estimate, Sales $69.000K Miss $150.000K Estimate

Here's Why VYNE Therapeutics (NASDAQ:VYNE) Must Use Its Cash Wisely

VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo

VYNE Therapeutics shares are trading lower after the company announced its Phase 2b trial Repibresib Gel in nonsegmental vitiligo did not meet its primary endpoint.

HC Wainwright & Co. Downgrades VYNE Therapeutics to Neutral

VYNE Therapeutics Announces Phase 2b Trial With Repibresib Gel In Nonsegmental Vitiligo Did Not Meet Primary Endpoint Or Key Secondary Endpoint of F-VASI50 And F-VASI75

Trading Halt: Halted at 7:50:26 a.m. ET - Trading Halt: Halt News Pending

Vyne Therapeutics: A Risky Bet On Upcoming Vitiligo Ph2b Readout